JP-1366 20mg

DRUG2 trials

Sponsors

Onconic Therapeutics Inc.

Conditions

Erosive EsophagitisGastric Ulcer

Phase 3

JP-1366 20mg Versus Esomeprazole 40mg in Patients With Erosive Esophagitis

CompletedNCT05443984

Onconic Therapeutics Inc.Erosive Esophagitis

Start: 2022-01-17End: 2023-01-05Updated: 2024-08-27

Clinical Trial to Evaluate the Efficacy and Safety of JP-1366 in Patients With Gastric Ulcer

CompletedNCT05448001

Onconic Therapeutics Inc.Gastric Ulcer

Start: 2022-09-19End: 2024-07-19Updated: 2024-08-26

Related Papers

Randomized, Double-Blind, Active-Controlled, Parallel, Phase 3 Clinical Trial for Evaluating the Efficacy and Safety of Zastaprazan in Patients with Gastric Ulcers.

2026-01-16